Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders
Annals of Bioethics & Clinical Applications – January 01, 2024
Source: OpenAlex
Summary
Advances in psychopharmacology have benefited thousands of patients, and psilocybin, a potent hallucinogen, is emerging as a promising treatment in Psychiatry. Preliminary evidence from Psychedelics and Drug Studies suggests marked improvements in mental health with psilocybin-assisted psychotherapy, delivered by a psychotherapist. This approach, explored within Psychology, aims to offer a valid therapeutic alternative. While safety and efficacy are primary objectives, some findings confirm psilocybin's safety in controlled environments, positioning it in Complementary and Alternative Medicine Studies.
Abstract
Psychedelics are a class of hallucinogenic drugs. They have been explored particularly for treatment-resistant psychiatric illnesses. In recent years, advances in psychopharmacology have benefited thousands of patients with some type of mental disorder. Preliminary evidence has shown that psilocybin has shown promise in the treatment of psychiatric disorders, with the support of qualified doctors. Recent clinical studies have reported marked improvements in mental health in psilocybinassisted psychotherapy. In many studies, the safety and efficacy of psilocybin have been the primary objectives to show that it is a safe and valid therapeutic alternative to other forms of psychiatric medications. Currently, some studies prove that psilocybin is safe in a controlled environment. However, the use of psilocybin needs to be further studied to determine the efficacy and safety of potential applications in medicine.